# RELPAX
> **NDA021016** · New Drug Application · Sponsor: UPJOHN · Approved 2002-12-26
## Drug
- **FDA Application Number:** NDA021016
- **Application type:** New Drug Application
- **Brand name:** RELPAX
- **Generic name:** ELETRIPTAN HYDROBROMIDE
- **Active ingredients:** ELETRIPTAN HYDROBROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UPJOHN
- **Manufacturer:** ROERIG
- **First approval:** 2002-12-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021016)
---
*AI Analytics · CC0 1.0*